Copyright Reports & Markets. All rights reserved.

Global Drugs for Anti-Infective Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Drugs for Anti-Infective Market Overview

      • 1.1 Product Overview and Scope of Drugs for Anti-Infective
      • 1.2 Drugs for Anti-Infective Segment by Type
        • 1.2.1 Global Drugs for Anti-Infective Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 OTC
        • 1.2.3 Rx Drugs
      • 1.3 Drugs for Anti-Infective Segment by Application
        • 1.3.1 Drugs for Anti-Infective Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Drugs Store
        • 1.3.4 Other
      • 1.4 Global Drugs for Anti-Infective Market by Region
        • 1.4.1 Global Drugs for Anti-Infective Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Drugs for Anti-Infective Market Size
        • 1.5.1 Global Drugs for Anti-Infective Revenue (2014-2025)
        • 1.5.2 Global Drugs for Anti-Infective Production (2014-2025)

      2 Global Drugs for Anti-Infective Market Competition by Manufacturers

      • 2.1 Global Drugs for Anti-Infective Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Drugs for Anti-Infective Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Drugs for Anti-Infective Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Drugs for Anti-Infective Production Sites, Area Served, Product Types
      • 2.5 Drugs for Anti-Infective Market Competitive Situation and Trends
        • 2.5.1 Drugs for Anti-Infective Market Concentration Rate
        • 2.5.2 Drugs for Anti-Infective Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Drugs for Anti-Infective Production Market Share by Regions

      • 3.1 Global Drugs for Anti-Infective Production Market Share by Regions
      • 3.2 Global Drugs for Anti-Infective Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Drugs for Anti-Infective Production
        • 3.4.1 North America Drugs for Anti-Infective Production Growth Rate (2014-2019)
        • 3.4.2 North America Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Drugs for Anti-Infective Production
        • 3.5.1 Europe Drugs for Anti-Infective Production Growth Rate (2014-2019)
        • 3.5.2 Europe Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Drugs for Anti-Infective Production (2014-2019)
        • 3.6.1 China Drugs for Anti-Infective Production Growth Rate (2014-2019)
        • 3.6.2 China Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Drugs for Anti-Infective Production (2014-2019)
        • 3.7.1 Japan Drugs for Anti-Infective Production Growth Rate (2014-2019)
        • 3.7.2 Japan Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Drugs for Anti-Infective Consumption by Regions

      • 4.1 Global Drugs for Anti-Infective Consumption by Regions
      • 4.2 North America Drugs for Anti-Infective Consumption (2014-2019)
      • 4.3 Europe Drugs for Anti-Infective Consumption (2014-2019)
      • 4.4 China Drugs for Anti-Infective Consumption (2014-2019)
      • 4.5 Japan Drugs for Anti-Infective Consumption (2014-2019)

      5 Global Drugs for Anti-Infective Production, Revenue, Price Trend by Type

      • 5.1 Global Drugs for Anti-Infective Production Market Share by Type (2014-2019)
      • 5.2 Global Drugs for Anti-Infective Revenue Market Share by Type (2014-2019)
      • 5.3 Global Drugs for Anti-Infective Price by Type (2014-2019)
      • 5.4 Global Drugs for Anti-Infective Production Growth by Type (2014-2019)

      6 Global Drugs for Anti-Infective Market Analysis by Applications

      • 6.1 Global Drugs for Anti-Infective Consumption Market Share by Application (2014-2019)
      • 6.2 Global Drugs for Anti-Infective Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Drugs for Anti-Infective Business

      • 7.1 GlaxoSmithKline
        • 7.1.1 GlaxoSmithKline Drugs for Anti-Infective Production Sites and Area Served
        • 7.1.2 Drugs for Anti-Infective Product Introduction, Application and Specification
        • 7.1.3 GlaxoSmithKline Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Merck
        • 7.2.1 Merck Drugs for Anti-Infective Production Sites and Area Served
        • 7.2.2 Drugs for Anti-Infective Product Introduction, Application and Specification
        • 7.2.3 Merck Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Pfizer
        • 7.3.1 Pfizer Drugs for Anti-Infective Production Sites and Area Served
        • 7.3.2 Drugs for Anti-Infective Product Introduction, Application and Specification
        • 7.3.3 Pfizer Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Novartis AG
        • 7.4.1 Novartis AG Drugs for Anti-Infective Production Sites and Area Served
        • 7.4.2 Drugs for Anti-Infective Product Introduction, Application and Specification
        • 7.4.3 Novartis AG Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Gilead Sciences
        • 7.5.1 Gilead Sciences Drugs for Anti-Infective Production Sites and Area Served
        • 7.5.2 Drugs for Anti-Infective Product Introduction, Application and Specification
        • 7.5.3 Gilead Sciences Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Abbott
        • 7.6.1 Abbott Drugs for Anti-Infective Production Sites and Area Served
        • 7.6.2 Drugs for Anti-Infective Product Introduction, Application and Specification
        • 7.6.3 Abbott Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Wyeth
        • 7.7.1 Wyeth Drugs for Anti-Infective Production Sites and Area Served
        • 7.7.2 Drugs for Anti-Infective Product Introduction, Application and Specification
        • 7.7.3 Wyeth Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Sanofi-Aventis
        • 7.8.1 Sanofi-Aventis Drugs for Anti-Infective Production Sites and Area Served
        • 7.8.2 Drugs for Anti-Infective Product Introduction, Application and Specification
        • 7.8.3 Sanofi-Aventis Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Bristol-Myers Squibb
        • 7.9.1 Bristol-Myers Squibb Drugs for Anti-Infective Production Sites and Area Served
        • 7.9.2 Drugs for Anti-Infective Product Introduction, Application and Specification
        • 7.9.3 Bristol-Myers Squibb Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Johnson
        • 7.10.1 Johnson Drugs for Anti-Infective Production Sites and Area Served
        • 7.10.2 Drugs for Anti-Infective Product Introduction, Application and Specification
        • 7.10.3 Johnson Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Roche Pharma AG
      • 7.12 Nanosphere
      • 7.13 NanoViricides
      • 7.14 Novabay Pharmaceuticals
      • 7.15 Obetech
      • 7.16 Optimer Pharmaceuticals
      • 7.17 Basilea Pharmaceutica AG
      • 7.18 Daiichi Sankyo
      • 7.19 MerLion Pharma
      • 7.20 Theravance

      8 Drugs for Anti-Infective Manufacturing Cost Analysis

      • 8.1 Drugs for Anti-Infective Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Drugs for Anti-Infective
      • 8.4 Drugs for Anti-Infective Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Drugs for Anti-Infective Distributors List
      • 9.3 Drugs for Anti-Infective Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Drugs for Anti-Infective Market Forecast

      • 11.1 Global Drugs for Anti-Infective Production, Revenue Forecast
        • 11.1.1 Global Drugs for Anti-Infective Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Drugs for Anti-Infective Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Drugs for Anti-Infective Price and Trend Forecast (2019-2025)
      • 11.2 Global Drugs for Anti-Infective Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Drugs for Anti-Infective Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Drugs for Anti-Infective Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Drugs for Anti-Infective Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Drugs for Anti-Infective Production, Revenue Forecast (2019-2025)
      • 11.3 Global Drugs for Anti-Infective Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Drugs for Anti-Infective Consumption Forecast (2019-2025)
        • 11.3.2 Europe Drugs for Anti-Infective Consumption Forecast (2019-2025)
        • 11.3.3 China Drugs for Anti-Infective Consumption Forecast (2019-2025)
        • 11.3.4 Japan Drugs for Anti-Infective Consumption Forecast (2019-2025)
      • 11.4 Global Drugs for Anti-Infective Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Drugs for Anti-Infective Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.

        The global Drugs for Anti-Infective market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Drugs for Anti-Infective volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drugs for Anti-Infective market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        GlaxoSmithKline
        Merck
        Pfizer
        Novartis AG
        Gilead Sciences
        Abbott
        Wyeth
        Sanofi-Aventis
        Bristol-Myers Squibb
        Johnson
        Roche Pharma AG
        Nanosphere
        NanoViricides
        Novabay Pharmaceuticals
        Obetech
        Optimer Pharmaceuticals
        Basilea Pharmaceutica AG
        Daiichi Sankyo
        MerLion Pharma
        Theravance

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        OTC
        Rx Drugs

        Segment by Application
        Hospital
        Drugs Store
        Other

        Buy now